Total Payments
$6,703
2024 Payments
$20.82
Companies
28
Transactions
193
Medicare Patients
401
Medicare Billing
$47,843
Payment Breakdown by Category
Food & Beverage$5,112 (76.3%)
Consulting$1,590 (23.7%)
Education$1.15 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,112 | 191 | 76.3% |
| Consulting Fee | $1,590 | 1 | 23.7% |
| Education | $1.15 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,941 | 11 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $851.71 | 15 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $660.49 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $474.38 | 20 | $0 (2018) |
| PFIZER INC. | $426.65 | 25 | $0 (2019) |
| Allergan Inc. | $228.37 | 10 | $0 (2018) |
| Cumberland Pharmaceuticals, Inc. | $216.54 | 12 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $199.17 | 6 | $0 (2018) |
| Relypsa, Inc. | $187.74 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $166.19 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.82 | 1 | AstraZeneca Pharmaceuticals LP ($20.82) |
| 2023 | $1,613 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($1,590) |
| 2022 | $25.35 | 1 | AstraZeneca Pharmaceuticals LP ($25.35) |
| 2021 | $523.11 | 13 | AstraZeneca Pharmaceuticals LP ($372.50) |
| 2020 | $264.55 | 9 | AstraZeneca Pharmaceuticals LP ($197.21) |
| 2019 | $928.17 | 34 | Merck Sharp & Dohme Corporation ($237.86) |
| 2018 | $1,543 | 52 | Merck Sharp & Dohme Corporation ($355.16) |
| 2017 | $1,785 | 81 | Boehringer Ingelheim Pharmaceuticals, Inc. ($318.60) |
All Payment Transactions
193 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2023 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,590.00 | General |
| 03/09/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.35 | General |
| 08/19/2021 | AbbVie Inc. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/15/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: COVID-19 | ||||||
| 06/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $104.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/27/2021 | AbbVie Inc. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/26/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $130.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/28/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/24/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/03/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/02/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/21/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $15.14 | General |
| 01/05/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2020 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 02/27/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/18/2020 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 100 | 165 | $29,106 | $12,474 |
| 2022 | 2 | 32 | 51 | $10,110 | $3,969 |
| 2021 | 3 | 110 | 168 | $26,750 | $13,938 |
| 2020 | 3 | 159 | 263 | $34,360 | $17,462 |
Total Patients
401
Total Services
647
Medicare Billing
$47,843
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 68 | 132 | $18,216 | $7,736 | 42.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 32 | 33 | $10,890 | $4,738 | 43.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 16 | 16 | $5,280 | $2,074 | 39.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 16 | 35 | $4,830 | $1,895 | 39.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 61 | 110 | $17,600 | $9,390 | 53.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 31 | 31 | $6,045 | $2,808 | 46.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 27 | $3,105 | $1,741 | 56.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 102 | 205 | $23,575 | $12,344 | 52.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 42 | 43 | $8,385 | $3,814 | 45.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 15 | 15 | $2,400 | $1,304 | 54.3% |
About Dr. John Yaft, MD
Dr. John Yaft, MD is a Internal Medicine healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2010. The National Provider Identifier (NPI) number assigned to this provider is 1104147982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Yaft, MD has received a total of $6,703 in payments from pharmaceutical and medical device companies, with $20.82 received in 2024. These payments were reported across 193 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,112).
As a Medicare-enrolled provider, Yaft has provided services to 401 Medicare beneficiaries, totaling 647 services with total Medicare billing of $47,843. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Irving, TX
- Active Since 06/16/2010
- Last Updated 08/19/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104147982
Products in Payments
- ZERBAXA (Drug) $670.19
- XARELTO (Drug) $474.38
- FARXIGA (Drug) $446.38
- ELIQUIS (Drug) $302.39
- BRILINTA (Drug) $188.76
- Veltassa (Drug) $187.74
- ENTRESTO (Drug) $166.19
- CLEVIPREX (Drug) $164.48
- DIFICID (Drug) $158.30
- Caldolor (Drug) $156.68
- Kcentra (Biological) $148.55
- CHANTIX (Drug) $133.93
- LANTUS (Drug) $128.00
- BEVYXXA (Drug) $114.75
- AVYCAZ (Drug) $114.62
- RELISTOR (Drug) $114.03
- TEFLARO (Drug) $113.75
- SAMSCA (Drug) $82.52
- Smoflipid (Drug) $79.46
- Reveal LINQ (Device) $63.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irving
Dr. Samata Basani, M.d, M.D
Internal Medicine — Payments: $302,290
Internal Medicine $302,290
Dr. Shiraj Sen, M.d, M.D
Internal Medicine — Payments: $81,865
Internal Medicine $81,865
Branden Snyder, M.d, M.D
Internal Medicine — Payments: $29,735
Internal Medicine $29,735
Ahmed Iqbal, M.d, M.D
Internal Medicine — Payments: $24,674
Internal Medicine $24,674
Nauman Siddiqi, Md, MD
Internal Medicine — Payments: $19,851
Internal Medicine $19,851
Dr. Enid Romanelli, M.d, M.D
Internal Medicine — Payments: $14,115
Internal Medicine $14,115